# 01 — Original Request and Verbatim Dialogue Ledger (PRICEPOINT-001, Stages 1–2)

| Field | Value |
|---|---|
| Project | PricePoint — AI-Augmented Pricing & Revenue Decision System (Dataset 3 of 3) |
| Run ID | PRICEPOINT-001 |
| Stakeholder | Morgan Lee, fictional Pricing & Revenue Manager (SYNTHETIC; simulated by Grok Bot in the Morgan Lee Simulator role) |
| Human analyst / owner | Mark (human owner); Grok Bot acts as Framework Coordinator and relays AI 1's drafted messages unedited |
| Dialogue Lead | AI 1 = ChatGPT |
| Independent reviewers | AI 2 = Grok (decision reconstruction); AI 3 = DeepSeek (red team) |
| Mode | Simulated stakeholder dialogue (synthetic; not real stakeholder validation) |
| Time zone | America/Chicago (CT) |

## Phase A — Intake

- Stakeholder role: Pricing & Revenue Manager (fictional).
- Human analyst: Mark (owner).
- Context: portfolio evaluation project; data available are M5 daily unit sales, weekly shelf prices, and calendar (events, SNAP). No cost, margin, inventory, competitor, or customer data.
- Provisional classification: unclear / recommendation-adjacent pricing request. The requested output ("which products we should be changing prices on") is not yet a locked decision.

---

## Turn T000 — Stakeholder opening (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Phase: Start
- Exact wording:
> I keep hearing we're leaving money on the table with our shelf prices. Can you dig into our sales and price history and tell me which products we should be changing prices on? I'd like something I can actually use at our next pricing review.

- Analytical effect: Incomplete pricing/revenue request recorded. Decision owner, action set, outcome, constraint, and time scope not yet established.

---

## Turn T001 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT, GPT-5.6 Sol, reasoning High 3 of 4 — highest level available on the Plus plan; 4 of 4 requires an upgrade), relayed unedited by the Framework Coordinator
- Source: reviews/ai1_T001_raw.txt (chat https://chatgpt.com/c/6ab614b5-44a4-83e9-bf78-075f0421b5d8)
- Phase: Start
- Exact wording:
> Thanks, Morgan. It sounds like you want to use the sales and price history to support a pricing review decision, specifically around where current shelf prices may not be capturing available revenue opportunities.
> 
> Examples of decisions this analysis might support are:
> 
> * whether to increase prices on selected products where the business believes there may be room to capture more revenue,
> * whether to reduce prices on selected products where a price change could improve sales outcomes,
> * whether to leave certain products unchanged because the current pricing appears appropriate.
> 
> These are examples of possible decisions, not the only options. Which decision are you trying to make at the pricing review?
- Analytical effect: Acknowledged request; offered three action-type examples (increase, reduce, hold) labelled non-exhaustive; asked which decision she is trying to make.

---

## Turn T002 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic; Morgan Lee Simulator)
- Phase: Start
- Exact wording:
> Honestly, it's all three — that's what a pricing review is. For each product we look at, I have to walk in with a recommendation: raise the shelf price, take a targeted price cut, or leave it where it is. I make the recommendation and the store general manager signs off. What I don't have is a good way to tell which of those three is the right call for a given product.

- Analytical effect: Decision is a per-product three-way recommendation (raise / targeted cut / hold) at the pricing review. Recommender is Morgan; approver is the store GM. Outcome, scope (which products/stores), constraint, horizon, guardrail, and uncertainty tolerance not yet established.

---

## Phase C/D record (round 1)
- AI 2 Start review R1: reviews/ai2_start_review_r1_raw.txt (Grok Expert, https://grok.com/c/8dd288d4-7fec-48da-b3d8-258f909e56f0) — verdict Cannot yet frame.
- AI 3 Start review R1: reviews/ai3_start_review_r1_raw.txt (DeepSeek DeepThink, https://chat.deepseek.com/a/chat/s/443be5f9-2cfa-48bb-b16c-e379844fed46) — verdict Cannot yet frame.
- Both frozen with SHA-256 (reviews/SHA256SUMS_r1.txt) before being shown to AI 1.
- AI 1 reconciliation: reviews/ai1_T003_raw.txt (Section 0). Accepted AI 3's T001 leading-language critique; carried the one-decision vs per-product-review concern as a Start/Framing issue to resolve with the stakeholder.

## Turn T003 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T003_raw.txt
- Exact wording:
> Thanks, Morgan. I understand that your pricing review requires a recommendation for each product you evaluate: raise the shelf price, take a targeted price cut, or leave it unchanged, with you making the recommendation and the store general manager signing off.
>
> To make sure we define the decision correctly, what business result should determine whether one of those three actions is the right call for a product?

- Analytical effect: Confirms owner/actions; asks for the outcome criterion.

---

## Turn T004 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Revenue for the product — units sold times the shelf price — over the weeks after the change. I'd love to judge it on margin, but we don't have cost in this data, so revenue is the number I can actually defend with my GM. The right call is the one that's expected to bring in the most revenue for that product without doing something dumb to the customer.

- Analytical effect: Outcome = product revenue (units x shelf price) over a post-change period. Margin explicitly unavailable, stakeholder accepts revenue. Hints at a customer-side downside limit ("without doing something dumb to the customer") not yet defined. Horizon length not yet given.

---

## Turn T005 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T005_raw.txt
- Exact wording:
> Thanks, Morgan. That helps clarify the outcome you need to defend with your GM: the recommendation should aim to maximize expected product revenue, defined as units sold multiplied by shelf price over the weeks after the change, while avoiding a change that creates an unacceptable customer impact.
>
> To define the decision boundary, what level of downside would make you reject a revenue-increasing price recommendation (for example, a minimum acceptable unit-sales decline or another customer-impact concern)?

- Analytical effect: Restated outcome (expected product revenue over post-change weeks); asked for the downside level that would make her reject a revenue-increasing move.

---

## Turn T006 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Volume. If a move is expected to cut the product's units by more than about 10 percent, I don't want it, even if the revenue math says it comes out ahead. Losing that many shoppers on an item isn't a trade I'd take to my GM. A cut that brings units up is fine as long as the revenue holds.

- Analytical effect: Guardrail stated: reject any move expected to cut the product's units by more than about 10 percent, even if revenue rises. Cuts that raise units acceptable if revenue holds. 'About 10 percent' is a stakeholder candidate value; exact threshold is a Stage 3 lock with warrant-ledger entry.

---

## Turn T007 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T007_raw.txt
- Exact wording:
> Thanks, Morgan. That clarifies the constraint: you are not looking only for the highest expected revenue outcome; a recommendation also has to avoid an expected unit decline greater than about 10%, because that level of volume loss is not a trade-off you would take to your GM.
>
> Before I write the decision statement back for confirmation, is the pricing recommendation intended to apply to each product at a specific store, or should it be a product-level recommendation that applies across stores?

- Analytical effect: Restated guardrail; asked whether the recommendation is product-at-store or product across stores.

---

## Turn T008 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Each product at a specific store. Prices and shoppers differ store to store, so I'd rather not pretend one answer fits everywhere. For this first round I'd start with one store — our California pilot store — and the everyday grocery and household aisles. I'm not sure exactly which departments, so I'm open to your suggestion, but I don't want you guessing on products whose price has never moved or that barely sell.

- Analytical effect: Grain = product at a specific store. First-round scope: one California pilot store (M5 CA_1 is the candidate mapping, to confirm in Framing/Stage 3), everyday grocery and household aisles; departments open to analyst suggestion. Wants to exclude products with no price-movement history or very low sales — eligibility rule is a Stage 3 lock (warrant ledger).

---

## Turn T009 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T009_raw.txt
- Exact wording:
> Thanks, Morgan. That helps define the decision scope: you want recommendations at the product-by-store level rather than assuming one price decision applies everywhere. For this first round, you want to focus on one California pilot store and the everyday grocery and household aisles, while avoiding recommendations based on products with little sales activity or no meaningful price history.
>
> To define the remaining scope, what should determine whether a product is eligible for this first pricing review — for example, should we focus on products with a minimum sales volume, prior shelf-price changes, or another business rule?

- Analytical effect: Restated grain and first-round scope; asked what business rule should decide product eligibility.

---

## Turn T010 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Both, really. A product should have actually had its shelf price change at least a few times in the history, so there's something real to learn from, and it should sell steadily enough that a change would show up. I don't know what the right cutoffs are — that's your side of the table, as long as you tell me what you used and why. I'd rather have a smaller list I can trust than a big one full of guesses.

- Analytical effect: Eligibility principle: products with real shelf-price change history (several changes) and steady enough sales for a change to show. Cutoffs delegated to analyst with disclosure (Stage 3 lock, warrant ledger). Prefers smaller trustworthy list over a large speculative one.

---

## Turn T011 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T011_raw.txt
- Exact wording:
> Thanks, Morgan. That clarifies the review boundary: you want a smaller set of products where there is enough historical price movement and sales activity to make a recommendation defensible, rather than forcing decisions on products where the evidence is too thin. I’ll treat the specific eligibility cutoffs as an analytical design choice and document the rationale for them.
>
> For the timing of this decision, when is the next pricing review, and how long after a price change would you want to judge whether the recommendation worked?

- Analytical effect: Acknowledged eligibility principle (cutoffs = analytical design choice with rationale); asked for review timing and judgment horizon (one time-scope ambiguity).

---

## Turn T012 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> We review prices every four weeks, and whatever we set holds until the next review, so the next four weeks — 28 days — is the window I care about. For this exercise, treat the review as happening right at the end of the most recent history you have, and only use what we'd actually know as of that day.

- Analytical effect: Time scope: four-week pricing cycle; decision horizon = the 28 days after the review; review date = end of most recent available history; only information known as of that date may be used (no look-ahead).

---

## Turn T013 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T013_raw.txt
- Exact wording:
> Thanks, Morgan. That establishes the timing: recommendations are made at a four-week pricing review cadence, and the outcome window for judging a change is the following 28 days. I’ll also treat the review point as the end of the available history and avoid using information that would not have been available at that decision date.
>
> At the pricing review, what information would you expect to have available when making the raise, targeted cut, or hold recommendation?

- Analytical effect: Restated time scope (four-week cadence, 28-day horizon, decision at end of history, no look-ahead); asked what information is available at the review.

---

## Turn T014 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Just what's in our own history up to that day: daily unit sales for each product, the weekly shelf prices, and the calendar — holidays, events, and the SNAP benefit days, which really move grocery here. No competitor prices, no inventory, no cost. And to be clear, what I need walking in isn't just a recap of what happened last year — I need a sense of what to expect over the next four weeks at the current price versus at the price I'd be recommending.

- Analytical effect: Decision-time information: own history only — daily unit sales, weekly shelf prices, calendar (holidays/events, SNAP days). No competitor, inventory, or cost. Stakeholder needs a forward-looking expectation of the next 28 days at current price vs recommended price, not only a historical recap (business need; method not dictated).

---

## Turn T015 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T015_raw.txt
- Exact wording:
> Thanks, Morgan. That establishes the decision-time information boundary: the recommendation should use only the internal history available at the review date — daily unit sales, weekly shelf prices, and calendar factors such as holidays, events, and SNAP benefit days. It should not rely on competitor prices, inventory, cost data, or other information that would not be available.
>
> To complete the decision framing, how much uncertainty are you willing to accept before making a raise, targeted cut, or hold recommendation — for example, would you prefer fewer recommendations with stronger evidence, or more recommendations with lower confidence?

- Analytical effect: Restated decision-time information boundary; asked for uncertainty tolerance (fewer/stronger vs more/weaker).

---

## Turn T016 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Fewer, with stronger evidence. If the evidence on a product isn't solid, I want it to say "hold — not enough evidence" rather than push a change. I'd rather miss an opportunity than walk a bad price change into my GM's office, so I need a clear "can't tell" answer as a legitimate outcome, not a forced call.

- Analytical effect: Uncertainty tolerance: fewer recommendations with stronger evidence; weak evidence must yield an explicit 'hold — not enough evidence' / can't-tell outcome rather than a forced call; prefers missed opportunity over a bad change.

---

## Turn T017 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T017_raw.txt
- Exact wording:
> Thanks, Morgan. That completes the uncertainty preference: you want a smaller set of recommendations supported by stronger evidence, with “hold — not enough evidence” treated as a legitimate outcome rather than forcing a raise, cut, or hold decision when the evidence is insufficient.
>
> Here is my proposed decision statement based on what you’ve told me:
>
> **Morgan Lee, Pricing & Revenue Manager, must decide whether to recommend raising the shelf price, taking a targeted price cut, or leaving the shelf price unchanged for eligible products at the California pilot store’s everyday grocery and household aisles in order to maximize expected product revenue over the following 28 days, subject to avoiding expected unit declines greater than approximately 10% and only recommending changes when the available historical evidence is strong enough to support the decision. Products without sufficient evidence will receive a “hold — not enough evidence” outcome.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Presented first proposed decision statement for confirmation/correction.

---

## Turn T018 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Close, but you're missing something that matters in practice. My team can realistically work up about 25 price-change recommendations per four-week cycle — that's what we can get through with the GM. If more products than that qualify, I need to know which ones matter most so we take the strongest first. If fewer qualify, that's fine; don't pad the list to hit 25. Everything else reads right.

- Analytical effect: Correction (material): capacity constraint added — team can work up about 25 price-change recommendations per four-week cycle; if more qualify, strongest first (prioritization needed); if fewer, no padding. Remainder of statement accepted. Capacity treatment (hard attention budget) to be locked at Framing (capacity_stance); ranking key is a Stage 3 lock.

---

## Turn T019 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T019_raw.txt
- Exact wording:
> Thanks, Morgan. That adds an important operational constraint: the team can realistically work through about 25 price-change recommendations per four-week cycle with the GM. If more products qualify, the recommendations need to be prioritized by importance rather than expanding the list, and if fewer qualify, the process should not force additional recommendations.
>
> With that addition, should the 25-recommendation limit apply only to products where you are recommending an actual price change (raise or targeted cut), with “hold — not enough evidence” products excluded from that capacity limit?

- Analytical effect: Acknowledged capacity constraint; asked whether the ~25 cap applies only to raise/cut recommendations or also to hold outcomes.

---

## Turn T020 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Yes. The 25 is about actual price changes, raises or cuts, because those are what my team has to work up and walk through with the GM. Products that come out as "hold" or "hold — not enough evidence" don't count against it; I just need to see them listed so I know they were looked at.

- Analytical effect: Capacity boundary resolved: ~25 cap counts only actual price changes (raise or targeted cut); hold and hold-not-enough-evidence outcomes are outside the cap but must be listed as reviewed.

---

## Turn T021 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T021_raw.txt
- Exact wording:
> Thanks, Morgan. That completes the capacity rule: the 25-item limit applies only to actual price-change recommendations — raises or targeted cuts — that your team needs to prepare and review with the GM. Products assigned “hold” or “hold — not enough evidence” do not consume that capacity, but they should still be visible in the review output.
>
> Here is the proposed decision statement incorporating everything you have provided:
>
> **Morgan Lee, Pricing & Revenue Manager, must decide which eligible product-store combinations at the California pilot store’s everyday grocery and household aisles should receive a recommendation to raise the shelf price, take a targeted price cut, or remain unchanged, in order to maximize expected product revenue over the following 28 days, subject to avoiding expected unit declines greater than approximately 10%, using only information available at the end of the current history period, and limiting actual price-change recommendations to approximately 25 per four-week review cycle. When evidence is insufficient, the product should be classified as “hold — not enough evidence” rather than forcing a price change decision. If more than 25 products qualify for price changes, recommendations should be prioritized by importance; if fewer qualify, the list should not be padded.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Revised proposed decision statement incorporating the capacity rule (~25 actual price-change recommendations per cycle; holds outside the cap; prioritize if more qualify; no padding). Stakeholder confirmation pending; held until round-2 independent Start reviews and AI 1 reconciliation are complete.

---

## Phase C/D — Round-2 independent Start reviews and reconciliation (between T021 and T023)
- T021 was held and NOT shown to the stakeholder; it is a superseded draft. No turn T022 exists (no stakeholder reply to T021).
- AI 2 (Grok, Expert, new chat https://grok.com/c/51f808cb-7206-4501-956c-a48de2fa90a4): verdict Revise. Raw: reviews/ai2_start_review_r2_raw.txt
- AI 3 (DeepSeek, DeepThink, search off, new chat https://chat.deepseek.com/a/chat/s/dec6fcfe-2f85-4b45-8631-ba3a41d0f8bc): verdict Revise. Raw: reviews/ai3_start_review_r2_raw.txt
- Both frozen with SHA-256 (reviews/SHA256SUMS_r2.txt) before AI 1 saw them.
- AI 1 Phase D reconciliation: reviews/ai1_T023_raw.txt SECTION 0 (accepted capacity-interpretation, ranking-key, and beyond-top-25 ambiguities; deferred magnitude, eligibility and evidence thresholds to Framing/Stage 3).

---

## Turn T023 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T023_raw.txt
- Exact wording:
> Thanks, Morgan. Before I finalize the decision statement, I want to clarify one practical point about the 25 recommendation capacity: when more than 25 products appear to qualify for a raise or targeted cut, should the analysis produce only the top recommendations your team can work through with the GM, or should it provide a longer ranked list where your team works through the strongest ones first?

- Analytical effect: Post-reconciliation: asked whether the analysis should output only the top recommendations the team can work, or a longer ranked list worked strongest-first.

---

## Turn T024 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Give me the ranked list. The top ones, up to about 25, are what my team works up and takes to the GM. If more than that qualify, show the rest below the line as next in line so I know they're there, but they don't go into this cycle's package. By "strongest" I mean the biggest revenue gain that you actually trust; how you score that is your call, just tell me how you did it.

- Analytical effect: Capacity interpretation resolved: ranked list; top ~25 price changes form this cycle's package; any further qualifying products shown below the line as next in line (not in this cycle's package). 'Strongest' = biggest revenue gain that is trustworthy; scoring method delegated to analyst with disclosure (Stage 3 lock).

---

## Turn T025 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T025_raw.txt
- Exact wording:
> Thanks, Morgan. That clarifies how the capacity constraint works: the analysis should provide a ranked list, with the top recommendations — up to about 25 actual price changes — forming the package your team takes to the GM. Additional qualifying products should remain visible below the line as next in line, without entering the current cycle’s package. You also clarified that “strongest” means the largest expected revenue gain among recommendations you trust, with the scoring approach documented.
>
> With that clarification, is there anything else about the decision itself that would make you change or reject a recommendation before it reaches the GM?

- Analytical effect: Acknowledged ranked-list capacity rule and 'strongest' definition; asked whether any other condition would make her change or reject a recommendation before the GM.

---

## Turn T026 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Nothing new that would make me throw one out beyond what I've told you. One thing to keep in mind, though: whatever the GM signs off gets piloted, not rolled out blind. I know past price and sales patterns aren't proof of what a new price will actually do, so don't dress them up as a guarantee. Give me your honest expectation and I'll treat it as something to test.

- Analytical effect: No additional rejection condition. Causality/implementation context: approved changes are piloted, not rolled out blind; historical patterns are not proof of causal effect; expectations must not be presented as guarantees.

---

## Turn T027 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T027_raw.txt
- Exact wording:
> Thanks, Morgan. That completes the remaining decision context: the recommendations are intended to support a pilot, not a guaranteed rollout, and the evidence should be presented as an expectation based on past patterns rather than a promise of what the new price will do. I’ll treat the output as a testable recommendation with uncertainty made explicit.
>
> Here is the proposed decision statement incorporating everything you have provided:
>
> **Morgan Lee, Pricing & Revenue Manager, must decide which eligible product-store combinations at the California pilot store’s everyday grocery and household aisles should receive a recommendation to raise the shelf price, take a targeted price cut, or remain unchanged, with “hold — not enough evidence” used when the evidence is insufficient, in order to maximize expected product revenue (units sold × shelf price) over the following 28 days. The recommendation must avoid expected unit declines greater than approximately 10%, use only information available at the end of the most recent history period (daily unit sales, weekly shelf prices, and calendar information), and acknowledge that historical patterns provide expectations rather than guarantees of future price effects. The analysis should produce a ranked list: the strongest qualifying raise/cut recommendations, defined as the largest trusted expected revenue gains, form the approximately 25-item package the team works through with the GM; additional qualifying products remain visible below the line as next in line and do not enter the current cycle’s package. Products with insufficient evidence remain listed as hold — not enough evidence rather than receiving a forced recommendation.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Final proposed decision statement (supersedes T021) incorporating ranked-list capacity rule, 'strongest' definition, and pilot/expectation-not-guarantee context. Held for round-3 independent Start reviews before stakeholder confirmation.

---

## Phase C/D — Round-3 independent Start reviews (after T027)
- T027 held, not yet shown to stakeholder.
- AI 2 (Grok, Expert, new chat https://grok.com/c/169f7dc6-3382-4771-97b9-60a74beaedff): verdict Pass (noted omissions: pilot-not-rollout clause, SNAP emphasis, four-week cadence, GM sign-off, analyst diction). Raw: reviews/ai2_start_review_r3_raw.txt
- AI 3 (DeepSeek, DeepThink, search off, new chat https://chat.deepseek.com/a/chat/s/0c68c233-f9ed-41a3-a4ad-a455c1d20cb1): verdict Revise (recommend-vs-approve authority blurred; positive hold vs insufficient-evidence hold not separated; guardrail/capacity/next-in-line interaction ambiguous; scope/eligibility mapping). Raw: reviews/ai3_start_review_r3_raw.txt
- Frozen: reviews/SHA256SUMS_r3.txt before AI 1 saw them.

---

## Turn T029 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT) after round-3 Phase D reconciliation (reviews/ai1_T029_raw.txt SECTION 0), relayed unedited
- Source: reviews/ai1_T029_raw.txt
- Exact wording:
> Thanks, Morgan. I’ve incorporated your clarification that the GM package is built from a ranked list: the strongest trusted opportunities go into the current cycle up to your team’s capacity, while additional qualifying opportunities remain visible below the line as next in line. I’ve also kept the distinction between leaving a price unchanged and “hold — not enough evidence,” and treated the recommendations as pilot expectations rather than guarantees.
>
> Here is the revised decision statement:
>
> **Morgan Lee, Pricing & Revenue Manager, must determine what recommendation to bring to the store general manager for each eligible product at the California pilot store’s everyday grocery and household aisles: raise the shelf price, take a targeted price cut, leave the shelf price unchanged, or classify the product as “hold — not enough evidence” when the available evidence is not solid. The recommendation should identify the actions expected to produce the strongest trusted product revenue outcome (units sold × shelf price) over the next 28 days compared with the current price, while rejecting any change expected to reduce units by more than about 10%. The recommendation package should use only information available at the end of the most recent history period — daily unit sales, weekly shelf prices, and calendar information including holidays, events, and SNAP benefit days. Actual raise/cut recommendations should be ranked by the biggest trusted expected revenue gain, with the top approximately 25 prepared for GM review and additional qualifying items shown below the line as next in line. Approved changes will be piloted, and historical patterns should be presented as expectations to test rather than guarantees.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Revised final proposed decision statement (supersedes unsent T027; no T028 exists): Morgan framed as recommender to GM; unchanged vs hold-not-enough-evidence separated; pilot and SNAP wording restored. Held for reviewer verification of the reconciliation before stakeholder confirmation.

---

## Phase C/D — Round-3 verification of T029 (same reviewer chats)
- T029 held, not yet shown to stakeholder.
- AI 2 verification: Pass (omissions are documentation completeness: cadence, eligibility principles, holds-listed/no-pad). Raw: reviews/ai2_start_verify_r3_raw.txt
- AI 3 verification: Revise (price-change magnitude wrongly deferred given T014 "at the price I'd be recommending"; no-padding, holds-outside-cap, below-line-not-in-package omitted; product-store grain; aisle mapping stated as fixed). Raw: reviews/ai3_start_verify_r3_raw.txt
- Frozen: reviews/SHA256SUMS_r3.txt (appended) before AI 1 saw them.

---

## Turn T031 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT) after reconciling the T029 verification (reviews/ai1_T031_raw.txt SECTION 0), relayed unedited
- Source: reviews/ai1_T031_raw.txt
- Exact wording:
> Thanks, Morgan. I’ve incorporated the remaining clarifications: the GM package comes from a ranked list, the strongest items are the biggest trusted revenue gains, additional qualifying items remain below the line as next in line, and approved changes are treated as pilots rather than guarantees.
>
> Here is the revised decision statement:
>
> **Morgan Lee, Pricing & Revenue Manager, must determine what recommendation to bring to the store general manager for products meeting the review criteria at the California pilot store’s everyday grocery and household aisles: raise the shelf price, take a targeted price cut, leave the shelf price unchanged, or classify the product as “hold — not enough evidence” when the evidence is not solid. The recommendation should identify the actions expected to produce the strongest trusted product revenue result (units sold × shelf price) over the next 28 days compared with the current price, while rejecting changes expected to reduce units by more than about 10%. The review occurs on a four-week cycle, with the price decision holding until the next review. The recommendation uses only information available at the review date: daily unit sales, weekly shelf prices, and calendar information including holidays, events, and SNAP benefit days. The output is a ranked list: the strongest trusted raise/cut opportunities, up to about 25, form the GM package; additional qualifying opportunities remain below the line as next in line and are not included in that cycle’s package. Holds and hold — not enough evidence outcomes remain visible and do not consume the price-change capacity. Approved changes are pilots, and historical patterns should be presented as expectations to test rather than guarantees.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Revised final proposed decision statement (supersedes unsent T029; no T030 exists): adds four-week cadence and hold-until-next-review, 'products meeting the review criteria', no-padding/holds-outside-capacity/below-line-not-in-package. AI 1 rejected AI 3's view that price-change magnitude is Start-level (deferred to Framing/Stage 3). Held for reviewer verification.

---

## Phase C/D — Second verification of T031 (same reviewer chats)
- T031 held, not yet shown to stakeholder.
- AI 2: Pass; accepts deferral of price-change magnitude. Raw: reviews/ai2_start_verify2_raw.txt
- AI 3: Revise; magnitude is Start-level because T014 ("at the price I'd be recommending") and T024 ("biggest revenue gain") need a defined recommended price; also 'no padding' not explicit. Raw: reviews/ai3_start_verify2_raw.txt
- Frozen: reviews/SHA256SUMS_r3.txt (appended).
- COORDINATOR DECISION (Framework Coordinator, Grok Bot): the builder/red-team disagreement on magnitude persisted through two reconciliation passes and is not settled by vote. Whether the GM package carries a specific price is a fact only the stakeholder holds, and asking costs one turn. AI 1 is instructed to put that single question to Morgan (wording AI 1's own) before presenting the statement for confirmation, and to make the no-padding rule explicit. Disclosed to the owner at the Stage 1 checkpoint.

---

## Turn T033 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T033_raw.txt
- Exact wording:
> Thanks, Morgan. I’ve incorporated the remaining clarification points around the recommendation package, including the ranked list, the GM review capacity, the distinction between unchanged price and not-enough-evidence outcomes, and the pilot approach.
>
> For a raise or targeted price cut recommendation, does the recommendation you bring to the GM need to include a specific proposed new shelf price or change amount, or is identifying the direction of the change enough?

- Analytical effect: Asked whether a raise/cut recommendation must carry a specific proposed new shelf price or change amount, or only the direction.

---

## Turn T034 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> A specific price. My GM isn't going to sign off on "raise it a bit"; he needs the actual shelf price we'd pilot, and the expectation you give me for units and revenue should be at that price. How you come up with the candidate price is your call, just show me how you got there.

- Analytical effect: Recommendation granularity resolved: each raise/cut recommendation carries a specific proposed shelf price to pilot; 28-day unit and revenue expectations are stated at that price versus current; candidate-price construction delegated to analyst with disclosure (Stage 3).

---

## Turn T035 — Analyst message (Start)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T035_raw.txt
- Exact wording:
> Thanks, Morgan. That clarifies the recommendation format: the GM-facing recommendation needs to include the specific shelf price you would pilot, not only the direction of the change. The expected unit and revenue impact should be tied to that proposed pilot price, while the method for generating candidate prices can be documented separately.
>
> Here is the proposed decision statement incorporating that clarification:
>
> **Morgan Lee, Pricing & Revenue Manager, must determine what recommendation to bring to the store general manager for products meeting the review criteria at the California pilot store’s everyday grocery and household aisles: a specific pilot shelf price increase, a specific pilot shelf price cut, leaving the shelf price unchanged, or classifying the product as “hold — not enough evidence” when the available evidence is not solid. The recommendation should identify the specific pilot price expected to produce the strongest trusted product revenue result (units sold × shelf price) over the next 28 days compared with the current price, while rejecting changes expected to reduce units by more than about 10%. The review occurs on a four-week cycle, with the price decision holding until the next review. The recommendation uses only information available at the end of the most recent history period: daily unit sales, weekly shelf prices, and calendar information including holidays, events, and SNAP benefit days. The output is a ranked list: the strongest trusted price-change opportunities, based on the biggest revenue gain that is trusted, form the GM package up to about 25 actual price changes. If fewer qualify, the list is not padded. If more qualify, additional qualifying opportunities remain below the line as next in line and are not included in that cycle’s package. Holds and hold — not enough evidence outcomes remain visible and do not consume the price-change capacity. Approved changes are pilots, and historical patterns should be presented as expectations to test rather than guarantees.**
>
> Does this decision statement accurately describe the decision you need to make, or is there anything you would correct?

- Analytical effect: Final proposed decision statement incorporating the specific-pilot-price requirement (T034) and explicit no-padding rule. Held for final reviewer verification before stakeholder confirmation.

---

## Phase C — Final verification of T035 (same reviewer chats)
- AI 2: Pass (wording notes only). Raw: reviews/ai2_start_verify3_raw.txt
- AI 3: Pass, pending Morgan's confirmation. Raw: reviews/ai3_start_verify3_raw.txt
- Frozen: reviews/SHA256SUMS_r3.txt (appended) before stakeholder confirmation.
- T035 then relayed to the stakeholder unedited.

---

## Turn T036 — Stakeholder reply (Start)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Yes, that's it. That's the decision I need to walk into the GM with. I confirm it as written.

- Analytical effect: Stakeholder confirmation of the T035 decision statement (SYNTHETIC confirmation; not real stakeholder validation). Stage 1 now awaits human analyst (owner) approval.

---

# STAGE 2 — FRAMING (Phase E onward). Start Gate PASS and owner approval 2026-09-25 03:01 CT; `begin framing` AUTHORIZED. AI 1 packet: packets/AI1_FRAMING_T037.txt.

## Turn T037 — Analyst message (Framing)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T037_raw.txt
- Exact wording:
> Thanks, Morgan. We have the decision statement locked: the goal is to identify product-level price recommendations for the California pilot store that maximize trusted expected revenue over the next 28 days while respecting the unit guardrail, evidence standard, review capacity, and pilot approach.
>
> For the analysis design, what should matter most when deciding which qualifying recommendations deserve attention first: **the largest expected revenue opportunity**, **the highest confidence in the expected outcome**, or **a balance of revenue opportunity and confidence**?

- Analytical effect: First Framing question: priority philosophy (largest revenue opportunity vs highest confidence vs balance). AI 1 proposes capacity_stance hard_attention_budget (unit: actual raise/cut recommendations).

---

## Turn T038 — Stakeholder reply (Framing)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> A balance, I suppose, but not an even split. I'd rather miss an opportunity than make a bad move, so if you don't really trust what you expect to happen, it shouldn't be on the list at all. That's what the "not enough evidence" hold is for. Among the ones you do trust, put the biggest revenue gain first. How you decide what counts as trusted is your call; just tell me how you did it.

- Analytical effect: Confidence acts as a gate, not a weight: untrusted expectations become holds and do not rank; among trusted candidates, rank by biggest expected revenue gain. Trust criterion delegated to analyst with disclosure. Consistent with T024.

---

## Turn T039 — Analyst message (Framing)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT), relayed unedited
- Source: reviews/ai1_T039_raw.txt
- Exact wording:
> Thanks, Morgan. That clarifies the prioritization principle: this is not an even tradeoff between opportunity and confidence. Recommendations should first pass a trust standard; opportunities that are not sufficiently trusted should become “hold — not enough evidence” rather than entering the ranked list. Among the recommendations that do pass that standard, the largest trusted revenue gains should come first.
>
> For the analysis design, when you say you need to “trust” an expected outcome, should that trust primarily mean **the evidence supporting the expectation is strong**, **the expected revenue improvement is large enough to matter**, or **some combination of both**?

- Analytical effect: Asks the business meaning of 'trusted': evidence strength vs size of gain vs both. Candidate question C1 updated; capacity_stance hard_attention_budget held as established.

---

## Turn T040 — Stakeholder reply (Framing)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Mostly that the evidence is solid. The product's price has actually moved before, it sells enough to see what happened, and the expectation for the next four weeks isn't a guess. A small gain doesn't make something untrustworthy; it just ends up lower on the list. I don't have a number for "big enough to matter." If you think one is needed, that's your call; just tell me what you used.

- Analytical effect: Trust = strength of evidence (real past price movement, enough sales, forward expectation not a guess); gain size is a ranking matter, not a trust criterion. No materiality threshold from stakeholder; any minimum-gain rule is an analyst choice (Stage 3, disclose).

---

## Turn T041 — Analyst message (Framing) [HELD — not shown to Morgan pending Phase F review]
- Source: reviews/ai1_T041_raw.txt (SECTION 1 = draft stakeholder validation message; SECTION 2 = AI 1 builder output, candidate question C1, capacity_stance hard_attention_budget).
- Held per framework §14: stakeholder validation follows internal review.

## Phase F — Round-1 independent Framing reviews (on T041 builder output C1)
- Packets: packets/AI2_FRAMING_REVIEW_R1.txt, packets/AI3_FRAMING_REVIEW_R1.txt, plus packets/framing_dialogue_extract_T000_T040.txt (fresh chats).
- AI 2 (Grok, Expert, new chat https://grok.com/c/b918adb4-b8d8-485c-af9a-4871d62885b9): verdict Tighten (question omits ranked GM package up to ~25 with below-line list, and the grocery/household aisle scope; supports hard_attention_budget). Raw: reviews/ai2_framing_review_r1_raw.txt
- AI 3 (DeepSeek, DeepThink, search off, new chat https://chat.deepseek.com/a/chat/s/e8923a94-e418-4037-b941-b350aec1e361): verdict Pass (no blocking findings; capacity checked both directions; hard_attention_budget; offered stronger alternative wording incl. aisle scope, info boundary, ranking). Raw: reviews/ai3_framing_review_r1_raw.txt
- Both frozen with SHA-256 (reviews/SHA256SUMS_framing_r1.txt) before AI 1 saw them.
- Coordinator feasibility note (framing_feasibility_note.md; PC artifacts/framing/feasibility_probe_01.*) supplied to AI 1 for reconciliation.
- Reconciliation packet: packets/AI1_RECON_FRAMING_R1_T041R.txt
- AI 1 reconciliation: reviews/ai1_T041R_raw.txt. Accepted all AI 2 Tighten points and AI 3 wording suggestions on scope and ranking. C2 adopts AI 2's replacement wording (adds aisle scope, revenue definition, ranked GM package of up to ~25 actual price changes, and below-line list). Feasibility items carried to Stage 3 open work. T041R SECTION 1 HELD pending verification of the material revision (§14).
- Verification packets (same reviewer chats): packets/AI2_FRAMING_VERIFY_R1_T041R.txt, packets/AI3_FRAMING_VERIFY_R1_T041R.txt
- AI 2 verification (same chat): verdict Keep; all prior concerns resolved; no required changes. Raw: reviews/ai2_framing_verify_r1_raw.txt
- AI 3 verification (same chat): verdict Pass; no blocking findings; capacity checked both directions; hard_attention_budget. Raw: reviews/ai3_framing_verify_r1_raw.txt
- Hashes appended to reviews/SHA256SUMS_framing_r1.txt.

---

## Turn T041R — Analyst message (Framing, Phase G stakeholder validation)
- Speaker: Human analyst channel; drafted by AI 1 (ChatGPT) after Phase F reconciliation (reviews/ai1_T041R_raw.txt SECTION 1), relayed unedited. Supersedes held T041 (never shown).
- Exact wording:
> Thanks, Morgan. I’ve incorporated your clarification that the GM recommendation needs a specific pilot shelf price, while the method used to construct candidate prices will be documented rather than assumed. I’m also keeping the distinction that evidence strength determines whether an opportunity is trusted, and revenue gain ranks the trusted opportunities for the GM package.
>
> The analytical question I propose is:
>
> **For products meeting the review criteria in the California pilot store’s everyday grocery and household aisles, which specific pilot shelf prices should Morgan recommend for the next 28-day review cycle to produce the strongest trusted expected product revenue (units sold × shelf price) compared with the current price, without recommending a change expected to reduce units by more than about 10%; which products should instead remain unchanged or be classified as “hold — not enough evidence”; and which trusted price-change opportunities rank into the current-cycle GM package of up to about 25 actual price changes, with any additional qualifying opportunities listed below the line?**
>
> This supports the decision of what specific pilot price recommendation (or non-change outcome) Morgan should bring to the GM for the next pricing cycle.
>
> Does this analytical question accurately capture the decision you need supported, or would you correct anything before we move into design?

- Analytical effect: Presents candidate question C2 for stakeholder confirmation.

---

## Turn T042 — Stakeholder reply (Framing)
- Speaker: Morgan Lee (stakeholder, synthetic)
- Exact wording:
> Yes, that's the question I need answered. It covers the actual prices, the ones we leave alone or can't call yet, and the ranked list up to about 25 with the rest below the line. I approve it as written.

- Analytical effect: Stakeholder approves C2 as written (synthetic). No correction; no return to earlier gate.
